Sensei Biotherapeutics (SNSE) Earnings Date & Reports
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SNSE is expected to report earnings to fall 26.87% to -22 cents per share on May 13
Q1'25
Est.
$-0.23
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.04
The last earnings report on March 28 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 446.62K shares outstanding, the current market capitalization sits at 12.78M.